Results 101 to 110 of about 331 (147)

Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma atient-centred Intervention Network (SPIN) Cohort Study. [PDF]

BMJ Open, 2020
Sommer SJ, Harel D, Kwakkenbos L, Carrier ME, Gholizadeh S, Gottesman K, Leite C, Malcarne VL, Thombs BD, SPIN Investigators.   +9 more
europepmc   +1 more source

Fenómeno de Raynaud y esclerodermia

Atención Primaria, 2003
Ezquerra Gadea, J., López Larrayoz, I., García Cores, F., García Muñoz, M.   +3 more
openaire   +1 more source

Riesgo de cáncer en la esclerodermia

, 2017
Objetivo: Existen pruebas convincentes que muestran un incremento del riesgo de cáncer en pacientes con esclerodermia (esclerosis sistémica, ES), por lo que la identificación de factores de riesgo de neoplasia puede tener implicaciones en el pronóstico de esta enfermedad autoinmune.
openaire   +1 more source

Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy--report of five patients. [PDF]

An Bras Dermatol, 2013
Zanelato TP, Marquesini G, Colpas PT, Magalhães RF, Moraes AM.   +4 more
europepmc   +1 more source

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. [PDF]

J Psychosom Res, 2020
Thombs BD, Kwakkenbos L, Carrier ME, Bourgeault A, Tao L, Harb S, Gagarine M, Rice D, Bustamante L, Ellis K, Duchek D, Wu Y, Bhandari PM, Neupane D, Carboni-Jiménez A, Henry RS, Krishnan A, Sun Y, Levis B, He C, Turner KA, Benedetti A, Culos-Reed N, El-Baalbaki G, Hebblethwaite S, Bartlett SJ, Dyas L, Patten S, Varga J, Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory Team, SPIN Investigators.   +30 more
europepmc   +1 more source

Esclerodermia sistémica

EMC - Tratado de Medicina, 2009
openaire   +1 more source

Estado nutricional em doentes com esclerodermia

, 2013
Introdução: A Esclerose Sistémica (ES) é uma doença multissistémica que interfere com o estado de nutrição. O principal objectivo deste trabalho foi avaliar o estado de nutrição e composição corporal numa população de doentes com ES, avaliando eventual relação com capacidade funcional, tempo de evolução e actividade/gravidade da doença.
openaire   +1 more source

[Bone dysplasias: a presentaion of a family history]. [PDF]

Aten Primaria, 2011
García Ruiz-Rozas J, Orenga Lozano ME, Mayol Jiménez P.   +2 more
europepmc   +1 more source

Hand dysfunction in scleroderma patients. [PDF]

Sao Paulo Med J, 2011
Skare TL, Toebe BL, Boros C.
europepmc   +1 more source

Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. [PDF]

BMJ Open, 2019
Harel D, Mills SD, Kwakkenbos L, Carrier ME, Nielsen K, Portales A, Bartlett SJ, Malcarne VL, Thombs BD, SPIN Investigators.   +9 more
europepmc   +1 more source